源自Antibody Engineering & Therapeutics系列背后的团队
抗体工程与治疗学系列会议已连续举办超过30年，确立了自身在抗体工程领域历史最悠久、影响力最广泛的会议系列之一。其旗舰级美国年会三十多年来汇聚全球顶尖学术与产业专家，共同分享前沿研究、技术进展及疗法突破。
步入为期2天的突破性科学、战略对接与颠覆性机遇。ChinaBioTM的Antibody&ADC专场将全球最具活力的抗体和ADC创新生态系统汇聚于上海。
来自抗体工程、双特异性抗体和ADC领域全球先驱的洞见
涵盖从抗体治疗和ADC发现到临床的专题演讲
通过partneringONE进行1V1合作会议，将对话转化为合作伙伴关系
炉边对话，探讨CDMO合作伙伴关系如何超越交易型关系
Let’s talk science
通过两个专题专场深入细节，涵盖从抗体工程和双特异性设计到ADC载荷、连接子化学和临床更新的一切动态。
Antibody Engineering & Antibody Therapeutics
- Bispecific and Multispecific Antibodies
- Novel Techniques for Antibody Engineering
- Dual-specific Antibodies
- Gated Antibodies
- Novel Engineering Strategies to Avoid Toxicity of T-cell Engagers
- Antibodies for Novel Targets
- Applications of AI and ML in Antibody Development & Drug Discovery
- Multi-objective Lead Optimization Using AI/ML
- De Novo Hit Discovery Using AI and ML
- Preclinical and Clinical Updates on PD1/PDL1/VEGF Bispecifics
- Antibodies for Autoimmune Diseases
- Antibodies for Immunity and Inflammation
Antibody-Drug Conjugates
- Novel ADC Payloads
- Tumor-specific Release of Payloads
- Multi-payloads for ADCs
- Mechanisms of how ADCs work: Internalization, ADC tumor killing, Antigen Expression Levels and Interactions
- Linker chemistry strategy (biology and chemistry)
- Conditional Antibody Binding
- Pharmacology and Mechanisms of ADCs: Metabolic Rate, Tumor Penetration
- ADC Clinical Updates
- Innovations in ADC Manufacturing
获取最新活动更新
注册以获取最新的活动更新和信息。
我们不会在未经同意的情况下分享任何数据
任何联系您售卖参会者名单的外部供应商都未经大会主办方批准，与大会主办方无关。
